XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Research and Development Costs
6 Months Ended
Jun. 30, 2024
Research and Development [Abstract]  
Research and Development Costs

3. Research and Development Costs

 

A summary of research and development costs for the three months and six months ended June 30, 2024 and 2023, including costs associated with clinical trials involving the Company’s lead clinical compound LB-100, are summarized below based on the respective geographical regions where such costs have been incurred.

 

Schedule of Research and Development Costs 

             
  

Three Months Ended

June 30,

  

Six Months Ended

June 30,

 
   2024   2023   2024   2023 
                 
United States  $114,345   $87,625   $148,928   $223,531 
Spain   29,244    272,564    44,478    273,539 
China       14,090    2,282    14,090 
Netherlands   67,119    53,178    134,084    105,382 
Total  $210,708   $427,457   $329,772   $616,542